4.7 Article

Patient and caregiver reactions to clinical amyloid imaging

期刊

ALZHEIMERS & DEMENTIA
卷 13, 期 8, 页码 924-932

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jalz.2017.01.001

关键词

Amyloid imaging; Positron emission tomography; Diagnosis; Biomarker; Encounter

资金

  1. NIA [AG016570, AG016573]

向作者/读者索取更多资源

Introduction: Amyloid imaging is a tool that has recently become available to dementia specialists evaluating patients with possible Alzheimer's disease. Studies have assessed the impact of amyloid imaging on diagnostic and treatment decisions, but patient and family perspectives have received less attention. Methods: To examine how amyloid imaging affects the diagnostic experience of patients and families, we interviewed members of 26 patient-caregiver dyads with whom a neurologist discussed the option of amyloid positron emission tomography. Results: Most participants who chose to undergo amyloid imaging would choose to do so again. Regardless of the scan outcome, patients and caregivers commonly expressed relief on learning the scan results. Some participants expressed expectations that were beyond scan capabilities. Discussion: Amyloid imaging may provide information that patients and their families find useful. Clinicians must set correct expectations and ensure that families understand the limitations of amyloid imaging. (C) 2017 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据